X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (41830) 41830
Book Chapter (364) 364
Magazine Article (24) 24
Dissertation (7) 7
Publication (7) 7
Book / eBook (4) 4
Book Review (3) 3
Conference Proceeding (1) 1
Newspaper Article (1) 1
Reference (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26616) 26616
male (22333) 22333
cardiac & cardiovascular systems (17736) 17736
female (17065) 17065
animals (14902) 14902
middle aged (12128) 12128
aged (9346) 9346
heart failure (8561) 8561
heart (6990) 6990
ventricular function, left - drug effects (6854) 6854
adult (6829) 6829
echocardiography (6118) 6118
rats (5841) 5841
treatment outcome (5532) 5532
cardiology (5413) 5413
mortality (5235) 5235
risk factors (4726) 4726
time factors (4294) 4294
hypertension (4222) 4222
heart-failure (4184) 4184
heart failure - physiopathology (4158) 4158
pharmacology & pharmacy (4140) 4140
peripheral vascular disease (4114) 4114
cardiovascular (4040) 4040
electrocardiography (3938) 3938
physiology (3788) 3788
medicine & public health (3768) 3768
care and treatment (3553) 3553
analysis (3311) 3311
heart failure - drug therapy (3252) 3252
myocardium - metabolism (3201) 3201
ventricular function, left (3153) 3153
disease models, animal (3142) 3142
cardiomyopathy (3113) 3113
blood pressure - drug effects (3044) 3044
prognosis (3003) 3003
ventricular function, left - physiology (3002) 3002
myocardial contraction - drug effects (2960) 2960
prospective studies (2805) 2805
research (2805) 2805
heart attacks (2791) 2791
myocardial-infarction (2762) 2762
heart diseases (2759) 2759
hemodynamics - drug effects (2705) 2705
cardiac patients (2679) 2679
myocardium - pathology (2671) 2671
blood pressure (2657) 2657
follow-up studies (2635) 2635
left-ventricular dysfunction (2613) 2613
ventricular dysfunction, left - physiopathology (2578) 2578
cardiovascular disease (2577) 2577
heart - drug effects (2574) 2574
heart rate - drug effects (2475) 2475
myocardial infarction - physiopathology (2464) 2464
health aspects (2441) 2441
dogs (2390) 2390
left-ventricular function (2385) 2385
dysfunction (2384) 2384
mice (2380) 2380
hypertrophy (2372) 2372
left-ventricular hypertrophy (2362) 2362
stroke volume (2356) 2356
rats, sprague-dawley (2351) 2351
myocardial infarction (2345) 2345
therapy (2313) 2313
abridged index medicus (2290) 2290
ventricle (2173) 2173
ischemia (2170) 2170
drug therapy (2169) 2169
physiological aspects (2081) 2081
disease (2078) 2078
aged, 80 and over (2067) 2067
surgery (2037) 2037
acute myocardial-infarction (2024) 2024
hemodynamics (2002) 2002
retrospective studies (1980) 1980
cardiovascular diseases (1938) 1938
dose-response relationship, drug (1903) 1903
diagnosis (1881) 1881
stroke volume - drug effects (1877) 1877
myocardial infarction - drug therapy (1862) 1862
rats, wistar (1862) 1862
cardiovascular system (1851) 1851
ventricular function (1816) 1816
heart rate (1774) 1774
ventricular remodeling - drug effects (1768) 1768
cardiac arrhythmia (1758) 1758
angiotensin-converting enzyme inhibitors - therapeutic use (1751) 1751
survival (1713) 1713
hypertension - drug therapy (1712) 1712
medicine, general & internal (1711) 1711
hypertension - physiopathology (1704) 1704
patients (1670) 1670
heart failure - therapy (1659) 1659
risk (1646) 1646
adolescent (1627) 1627
in vitro techniques (1623) 1623
arrhythmia (1619) 1619
studies (1618) 1618
dilated cardiomyopathy (1611) 1611
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (41566) 41566
Japanese (252) 252
German (239) 239
Russian (196) 196
Chinese (170) 170
Portuguese (99) 99
French (82) 82
Spanish (71) 71
Italian (65) 65
Polish (43) 43
Ukrainian (23) 23
Czech (20) 20
Dutch (17) 17
Norwegian (13) 13
Turkish (11) 11
Hungarian (8) 8
Danish (4) 4
Slovak (3) 3
Korean (2) 2
Lithuanian (2) 2
Serbian (2) 2
Swedish (2) 2
Arabic (1) 1
Bosnian (1) 1
Croatian (1) 1
Finnish (1) 1
Hebrew (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 67, Issue 22, pp. 2593 - 2603
Journal Article
American journal of physiology. Heart and circulatory physiology, ISSN 1522-1539, 2018, Volume 314, Issue 2, pp. H311 - H321
...) or vehicle was administered daily starting at 3 wk post-TAC and continued for 12 wk. Echocardiography was performed to assess left ventricular (LV... 
Myocardial infarction | Hypertrophic cardiomyopathy | Mitochondria-targeted peptide | DNA repair | Mitochondrial injury | mitochondrial injury | APOPTOSIS | OXIDATIVE STRESS | PRESSURE-OVERLOAD | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | ARTERY ENDOTHELIAL-CELLS | MYOCARDIAL-INFARCTION | myocardial infarction | MITOCHONDRIAL-DNA DAMAGE | GLYCOSYLASE 1 PROTECTS | PERIPHERAL VASCULAR DISEASE | hypertrophic cardiomyopathy | MATRIX-METALLOPROTEINASE-9 EXPRESSION | mitochondria-targeted peptide | ISCHEMIA-REPERFUSION | SUPEROXIDE-DISMUTASE | Mitochondria, Heart - metabolism | Recombinant Fusion Proteins - pharmacology | Apoptosis - drug effects | DNA, Mitochondrial - drug effects | Mitochondria, Heart - pathology | Heart Failure - physiopathology | Male | Mitochondria, Heart - drug effects | DNA, Mitochondrial - genetics | Hypertrophy, Left Ventricular - pathology | Ventricular Dysfunction, Left - pathology | Hypertrophy, Left Ventricular - drug therapy | Disease Models, Animal | DNA Damage - drug effects | DNA, Mitochondrial - metabolism | Hypertrophy, Left Ventricular - metabolism | Mice, Inbred C57BL | Ventricular Function, Left - drug effects | Stroke Volume - drug effects | Heart Failure - metabolism | Heart Failure - pathology | Ventricular Dysfunction, Left - physiopathology | Apoptosis Regulatory Proteins - metabolism | Cardiovascular Agents - pharmacology | Heart Failure - drug therapy | Ventricular Dysfunction, Left - metabolism | Myocytes, Cardiac - pathology | Animals | Myocytes, Cardiac - drug effects | Ventricular Dysfunction, Left - drug therapy | Signal Transduction - drug effects | Fibrosis | Myocytes, Cardiac - metabolism | Hypertrophy, Left Ventricular - physiopathology | Oxidative Stress - drug effects | Ventricular Remodeling - drug effects | Heart failure | Mitochondrial DNA | Genetic aspects | Health aspects
Journal Article
Cardiovascular diabetology, ISSN 1475-2840, 2018, Volume 17, Issue 1, pp. 73 - 12
.... The effect of sodium-glucose cotransporter 2 inhibitors on left ventricular diastolic function has not been... 
Heart failure with preserved ejection fraction | Autonomic function | Left ventricular diastolic function | Type 2 diabetes mellitus | Sodium-glucose cotransporter 2 inhibitors | ERYTHROPOIETIN | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | DAPAGLIFLOZIN | CARDIOVASCULAR OUTCOMES | HEART-FAILURE | COTRANSPORTER 2 INHIBITION | EJECTION FRACTION | GLUCOSE | ENDOCRINOLOGY & METABOLISM | DYSFUNCTION | EMPAGLIFLOZIN | Prospective Studies | Diabetic Cardiomyopathies - drug therapy | Diabetic Cardiomyopathies - etiology | Diastole | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | Diabetic Cardiomyopathies - physiopathology | Recovery of Function | Time Factors | Canagliflozin - therapeutic use | Female | Diabetes Mellitus, Type 2 - complications | Diabetic Cardiomyopathies - diagnostic imaging | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Ventricular Function, Left - drug effects | Ventricular Dysfunction, Left - etiology | Treatment Outcome | Biomarkers - blood | Ventricular Dysfunction, Left - diagnostic imaging | Ventricular Dysfunction, Left - physiopathology | Blood Glucose - drug effects | Diabetes Mellitus, Type 2 - diagnosis | Diabetes Mellitus, Type 2 - blood | Pilot Projects | Ventricular Dysfunction, Left - drug therapy | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Drugs | Heart attacks | Multiple regression analysis | Angioplasty | Dyslipidemia | Clinical trials | Cardiovascular disease | Males | Hemoglobin | Blood pressure | Diabetes mellitus (non-insulin dependent) | Heart diseases | Heart failure | Hypertension | Medical research | Echocardiography | Parameters | Mortality | Diabetes mellitus | Health risks | Patients | Insulin | Coronary artery disease | Cholesterol | Sodium | Coronary vessels | Diabetes | Ventricle | Cardiovascular diseases | Health risk assessment | Females
Journal Article
Journal of the American Society of Nephrology, ISSN 1533-3450, 2014, Volume 25, Issue 1, pp. 175 - 186
Journal Article
PloS one, ISSN 1932-6203, 03/2016, Volume 11, Issue 3, p. e0149855
.... However, the impact of RDN in left ventricular (LV) mass and function is not completely established... 
REGRESSION | ATENOLOL | HYPERTROPHY | PRESSURE | DESIGN | RECOMMENDATIONS | RATIONALE | MULTIDISCIPLINARY SCIENCES | MASS | HYPERTENSION | SOCIETY | Prospective Studies | Follow-Up Studies | Humans | Systole - drug effects | Hypertension - drug therapy | Male | Sympathectomy - methods | Systole - physiology | Female | Ventricular Function, Left - physiology | Blood Pressure - drug effects | Diastole - drug effects | Blood Pressure Monitoring, Ambulatory - methods | Diabetes Mellitus, Type 2 - surgery | Kidney - surgery | Ventricular Function, Left - drug effects | Antihypertensive Agents - therapeutic use | Diastole - physiology | Hypertension - physiopathology | Blood Pressure Determination - methods | Diabetes Mellitus, Type 2 - physiopathology | Sympathetic Nervous System - surgery | Heart Ventricles - physiopathology | Kidney - innervation | Aged | Hypertrophy, Left Ventricular - physiopathology | Heart Ventricles - drug effects | Type 2 diabetes | Hypertension | Complications and side effects | Care and treatment | Usage | Physiological aspects | Research | Denervation | Heart | Drugs | Atrium | Mitral valve | Echocardiography | Kidneys | Deceleration | Diabetes mellitus | Medical instruments | Values | Males | Patients | Medical schools | Subgroups | Catheters | Impact resistance | Blood pressure | Ventricle | Veins & arteries | Structure-function relationships
Journal Article
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 12/2016, Volume 11, Issue 12, p. e0168340
.... This is a predefined substudy to determine an effect of metformin on diastolic function. For this substudy trans-thoracic echocardiography was performed during hospitalization and after 4 months... 
DIABETIC-PATIENTS | CARDIAC-FUNCTION | CHRONIC HEART-FAILURE | FILLING PATTERN | EJECTION FRACTION | PERCUTANEOUS INTERVENTION | TISSUE DOPPLER | EUROPEAN-SOCIETY | LEFT ATRIAL VOLUME | LEFT-VENTRICULAR FUNCTION | YOUNG-ADULTS | MULTIDISCIPLINARY SCIENCES | HEART-FAILURE | Echocardiography | Metformin - therapeutic use | Humans | Metformin - pharmacology | Middle Aged | Ventricular Function, Left - drug effects | Postoperative Complications - prevention & control | ST Elevation Myocardial Infarction - drug therapy | Male | ST Elevation Myocardial Infarction - diagnosis | Ventricular Dysfunction, Left - prevention & control | ST Elevation Myocardial Infarction - physiopathology | ST Elevation Myocardial Infarction - surgery | Female | Aged | Diastole - drug effects | Stents | Percutaneous Coronary Intervention | Complications and side effects | Heart beat | Patient outcomes | Physiological aspects | Dosage and administration | Metformin | Research | Drug therapy | Heart attack | Heart | Heart failure | Myocardial infarction | Animal models | Nuclear magnetic resonance--NMR | Heart attacks | Diabetes mellitus | Markers | Thorax | Medical diagnosis | Patients | Velocity | Randomization | Ultrasonic imaging | Flow velocity | Infarction | Diabetes | Ventricle | Cardiology | Elevation | NMR | Nuclear magnetic resonance
Journal Article
PloS one, ISSN 1932-6203, 2017, Volume 12, Issue 4, pp. e0175544 - e0175544
Aims 2 dimensional (2D) strain analysis detects subclinical left ventricular (LV) systolic dysfunction... 
GLOBAL LONGITUDINAL STRAIN | BREAST-CANCER | DEFORMATION INDEXES | EJECTION FRACTION | MULTIDISCIPLINARY SCIENCES | HEART-FAILURE | CARDIAC DYSFUNCTION | FOLLOW-UP | CARDIOTOXICITY | EUROPEAN ASSOCIATION | AMERICAN SOCIETY | Anthracyclines - adverse effects | Humans | Middle Aged | Echocardiography - methods | Stroke Volume - drug effects | Systole - drug effects | Breast Neoplasms - drug therapy | Breast Neoplasms - physiopathology | Ventricular Dysfunction, Left - chemically induced | Ventricular Dysfunction, Left - diagnostic imaging | Ventricular Dysfunction, Left - physiopathology | Anthracyclines - administration & dosage | Sensitivity and Specificity | Adult | Female | Aged | Diastole - drug effects | Anthracyclines | Chemotherapy | Analysis | Dosage and administration | Blood pressure | Cardiac output | Health aspects | Cancer | Clinical trials | Cardiovascular disease | Congestive heart failure | Doppler effect | Cancer therapies | Doxorubicin | Risk factors | Signal transduction | Ultrasonic imaging | Rodents | Surgery | Epirubicin | Cardiology | Strain rate | Heart failure | Creatinine | Stroke | Echocardiography | Epidermal growth factor receptors | Diabetes mellitus | Coronary artery | Breast cancer | Thorax | ErbB-2 protein | Cholesterol | Heart rate | Hospitals | Anthracycline | Death | Adrenergic receptors | Ventricle | Cardiovascular diseases | Index Medicus
Journal Article
American journal of physiology. Heart and circulatory physiology, ISSN 0363-6135, 2015, Volume 308, Issue 9, pp. H1020 - H1029
... beneficial effect on glucose homeostasis. The cardiovascular and metabolic effects of the sEH inhibitor trans-4-[4... 
Insulin resistance | Cardiac function | Soluble epoxide hydrolase | Endothelium | endothelium | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | HEART-FAILURE | RATS | MECHANISMS | soluble epoxide hydrolase | DIABETES-MELLITUS | CARDIOVASCULAR-DISEASE | PERIPHERAL VASCULAR DISEASE | cardiac function | DYSFUNCTION | HYPERTENSION | ARTERY | insulin resistance | EXPRESSION | Obesity - drug therapy | Coronary Vessels - physiopathology | Endothelium, Vascular - drug effects | Heart Diseases - prevention & control | Male | Endothelium, Vascular - enzymology | Obesity - blood | Dose-Response Relationship, Drug | Glyburide - pharmacology | Time Factors | Lipids - blood | Urea - analogs & derivatives | Inflammation Mediators - metabolism | Disease Models, Animal | Coronary Vessels - drug effects | Coronary Vessels - enzymology | Vasodilator Agents - pharmacology | Heart Diseases - physiopathology | Obesity - complications | Ventricular Function, Left - drug effects | Endothelium, Vascular - physiopathology | Enzyme Inhibitors - pharmacology | Insulin Resistance | Obesity - physiopathology | Heart Diseases - enzymology | Hypoglycemic Agents - pharmacology | Blood Glucose - drug effects | Heart Diseases - etiology | Animals | Eicosanoids - metabolism | Benzoates - pharmacology | Mice | Obesity - enzymology | Epoxide Hydrolases - metabolism | Vasodilation - drug effects | Blood Glucose - metabolism | Nitric Oxide - metabolism | Epoxide Hydrolases - antagonists & inhibitors | Ventricular Remodeling - drug effects | Urea - pharmacology | Prevention | Obesity | Enzymes | Physiological aspects | Hydrolases | Research | Heart diseases | Life Sciences | Call for Papers
Journal Article
Circulation (New York, N.Y.), ISSN 1524-4539, 2008, Volume 117, Issue 11, pp. 1388 - 1396
Background-Adverse cardiac remodeling and progression of heart failure after myocardial infarction are associated with excessive and continuous damage to the... 
Heart failure | Myocardial infarction | Tissue | Remodeling | Tissue engineering | Collagen | SURVIVAL | heart failure | remodeling | tissue engineering | HYDROGELS | CARDIAC & CARDIOVASCULAR SYSTEMS | NEOVASCULATURE FORMATION | MYOCARDIAL-INFARCTION | myocardial infarction | collagen | tissue | FAILURE | DELIVERY | MOLECULES | THERAPY | INJECTION | PERIPHERAL VASCULAR DISEASE | PDGF-BB | Viscosity | Alginates - therapeutic use | Biocompatible Materials - chemistry | Hexuronic Acids - administration & dosage | Male | Myocardial Infarction - diagnostic imaging | Injections, Intralesional | Hydrogels - administration & dosage | Myocardial Infarction - pathology | Ultrasonography | Glucuronic Acid - administration & dosage | Drug Evaluation, Preclinical | Glucuronic Acid - chemistry | Alginates - pharmacology | Cicatrix - diagnostic imaging | Myocardial Infarction - surgery | Drug Administration Schedule | Hypertrophy, Left Ventricular - etiology | Hypertrophy, Left Ventricular - prevention & control | Rats | Ventricular Dysfunction, Left - etiology | Glucuronic Acid - therapeutic use | Materials Testing | Biocompatible Materials - pharmacology | Hexuronic Acids - chemistry | Random Allocation | Rats, Sprague-Dawley | Ventricular Dysfunction, Left - diagnostic imaging | Ventricular Dysfunction, Left - prevention & control | Myocytes, Cardiac - transplantation | Alginates - administration & dosage | Glucuronic Acid - pharmacology | Animals | Myocardial Infarction - drug therapy | Alginates - chemistry | Biocompatible Materials - administration & dosage | Biocompatible Materials - therapeutic use | Cicatrix - pathology | Hydrogels - pharmacology | Hydrogels - therapeutic use | Ventricular Remodeling - drug effects | Hexuronic Acids - pharmacology | Hexuronic Acids - therapeutic use | Hypertrophy, Left Ventricular - diagnostic imaging | Prevention | Usage | Animal models in research | Patient outcomes | Development and progression | Drug therapy | Heart attack
Journal Article